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Purpose: To describe the early experience of analyzing variations and time trends in bladder volume of the rectal cancer patients 
who received bladder ultrasound scan.
Materials and Methods: We identified 20 consecutive rectal cancer patients who received whole pelvic radiotherapy (RT) and 
bladder ultrasound scan between February and April 2012. Before simulation and during the entire course of treatment, patients 
were scanned with portable automated ultrasonic bladder scanner, 5 times consecutively, and the median value was reported. Then 
a radiation oncologist contoured the bladder inner wall shown on simulation computed tomography (CT) and calculated its volume. 
Results: Before simulation, the median bladder volume measured using simulation CT and bladder ultrasound scan was 427 
mL (range, 74 to 1,172 mL) and 417 mL (range, 147 to 1,245 mL), respectively. There was strong linear correlation (R = 0.93, p < 
0.001) between the two results. During the course of treatment, there were wide variations in the bladder volume and every time, 
measurements were below the baseline with statistical significance (12/16). At 6 weeks after RT, the median volume was reduced by 
59.3% to 175 mL. Compared to the baseline, bladder volume was reduced by 38% or 161 mL on average every week for 6 weeks.
Conclusion: To our knowledge, this study is the first to prove that there are bladder volume variations and a reduction in bladder 
volume in rectal cancer patients. Moreover, our results will serve as the basis for implementation of bladder training to patients 
receiving RT with full bladder.
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Introduction
Preoperative chemoradiotherapy (CRT) has been established as 
a current standard treatment on locally advanced rectal cancer 
since several randomized controlled trials have confirmed that 
it improves local control and increases sphincter preservation 
rate [1-4]. Even after an upfront surgery of localized rectal 
cancer, for tumors with adverse pathological features (T3-4 
or N+ tumors), adjuvant CRT is known to improve oncologic 
outcome [5,6]. For rectal cancer patients, CRT on pelvic area 
is generally tolerable on most of the patients, but 8-40% of 
patients are reported to have acute toxicity (grade ≥3) and 
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24% of patients with late toxicity [1,7,8]. 
It is known that the risk of gastrointestinal (GI) complications 
is closely related to irradiated small bowel volume and dose 
within the radiation (RT) field [9]. There have been many 
studies to minimize irradiated small bowel volume and dose. 
Drzymara et al. [10] and Nijkamp et al. [11] reported that prone 
position was more effective than supine position in sparing 
small bowel. In the case of patients who are treated in prone 
position, using belly board or small bowel displacement device 
can move small bowel out of the RT field and, as a result, 
can lower the small bowel dose [12,13]. Therefore, in order 
to reduce GI complication risk in rectal cancer patients, our 
institution has been instructing all patients to maintain full 
bladder and treating them with belly board in prone position 
since 2009. 
However, to date, no study on whether rectal cancer patients 
have been maintaining the same bladder volume during the 
5 to 6 weeks of RT as they were during simulation has been 
published. Studies of bladder volume of cervix cancer and 
prostate cancer patients not only show wide inter-fraction 
variations in bladder volume during each RT but even a 
decrease in bladder volume during the course of treatment 
[14,15]. Therefore, in order to check bladder volume on a 
day by day basis just prior to RT, our institution introduced 
ultrasound bladder ultrasound scan in February 2011. The 
purpose of this study is to describe the early experience of 
analyzing variations and time trends in bladder volume of the 
20 consecutive rectal cancer patients who received bladder 
ultrasound scan after the introduction of the device. 
Materials and Methods
1. Study population
We identified 20 consecutive rectal cancer patients who 
received whole pelvic RT and bladder ultrasound scan between 
February 14 and April 15, 2012. The screening was performed 
after obtaining informed consent from all patients. Patients 
with the Eastern Cooperative Oncology Group (ECOG) 
performance status of 2 or higher, those who had functional 
disorder in their bladder, patients who underwent cystectomy, 
or those who showed strong aversion to retaining urine were 
excluded from bladder ultrasound scan. The clinical profiles of 
the 20 patients are shown in Table 1. 
2. Treatment
Fourteen patients (70%) received RT for preoperative aim and 
6 patients (30%) as postoperative aim. All patients received 
5-fluorouracil based concurrent chemotherapy plus RT. The 
former group comprised of patients with stage III mid-lower 
rectal cancer. One of the 6 patients in the latter group had 
stage I cancer and had received local excision before the 
CRT, while the other 5 patients had stage IIIB cancer and had 
undergone laparoscopy or robot assisted low anterior resection 
(LAR). Preoperative CRT patients received whole-pelvic RT of 
45 Gy followed by tumor bed boost of 5.4 Gy. On the other 
hand, Postoperative CRT patients only received whole-pelvic RT 
of 45 Gy, and additional boost of RT was given only according 
to their resection margin status. 
3. Bladder volume evaluation 
Patients were asked to drink unspecified volume of water 
because we thought there were wide variations of abilities 
in drinking water and retaining their urine. Instead, patients 
Table 1. Clinical profiles of 20 patients 
Characteristic No. (%)
Age (yr), median (range)
Gender
Female
Male
ECOG performance status
0
1
Tumor location
Lower rectum
Mid rectum
Upper rectum
Clinical T stage
T2
T3
T4
Clinical N stage
N0
N1
Clinical M stage
M0
Clinical stage
I
IIA
IIC
IIIB
IIIC
RT dose (Gy), median (range)
RT fraction, median (range)
50 (40-75)
10 (50)
10 (50)
1 (5)
19 (95)
8 (40)
11 (55)
1 (5)
1 (5)
13 (65)
6 (30)
4 (20)
16 (80)
20 (100)
1 (5)
2 (10)
1 (5)
12 (60)
4 (20)
50.4 (45-59.4)
28 (25-33)
ECOG, the Eastern Cooperative Oncology Group; RT, radiotherapy. 
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were instructed voluntarily at their first visit to regulate their 
volume of drinking water and time of retaining the urine so 
that the goal of the instructions was maintaining the similar 
desire to micturition before treatment. However, the patients 
were not forced to follow this protocol if they were not 
comfortable. During the simulation, patients were in prone 
position using bladder compression device and belly board 
designed by our institution. Details are included in previously 
reported paper [16]. Two trained doctors controlled the 
portable automated ultrasonic bladder scanner (Biocon-700; 
Mcube Technology, Seoul, Korea). Patients lied supine in a 
comfortable position. Then, scanner’s probe was placed on the 
midline of abdomen, two fingers over the symphysis pubic 
bone and angled towards the bladder. A three-dimensional 
real-time image before scanning was displayed to operators in 
order to locate easily the bladder position for more accurate 
measurement. Before simulation computed tomography (CT), 
patients were scanned 5 times consecutively, and the median 
value was reported. Then a radiation oncologist contoured 
the bladder inner wall shown on simulation CT and calculated 
its volume. During the entire course of treatment, patients’ 
bladder was scanned 3 days weekly (Monday, Wednesday, 
and Friday) just prior to the RT, and just as mentioned above, 
patients were scanned 5 times before reporting the median 
value. No additional planned instructions were provided to 
patients after full education at first visit. All measured volumes 
by bladder ultrasound scan were blinded to patients.
4. Data and statistical analysis 
In order to assess the accuracy of bladder ultrasound scan, 
Table 2. Time trends of bladder volume from CT scans and bladder scans 
No. of patient Median (mL) IQR (mL) Range (mL) p-value
VCT
VB-SCAN
V1-1 week
V1-2 week
V1-3 week
V2-1 week
V2-2 week
V2-3 week
V3-1 week
V3-2 week
V3-3 week
V4-1 week
V4-2 week
V4-3 week
V5-1 week
V5-2 week
V5-3 week
V6-1 week
V6-2 week
V6-3 week
20
20
19
18
15
17
19
18
20
19
19
19
19
19
19
17
16
16
10
  5
427
417
278
269
211
219
188
258
299
255
261
253
263
315
308
228
192
188
150
174
291
222
193
173
124
132
141
175
169
153
157
177
138
176
190
165
145
109
124
121
74-1,172
147-1,245
77-660
78-735
34-574
80-572
58-1,028
110-1,002
35-869
21-513
42-677
37-797
35-579
73-852
122-643
19-980
66-652
50-917
109-210
62-257
-
-
0.053
0.008
0.005
0.019
0.053
0.061
0.055
0.049
0.036
0.046
0.049
0.126
0.033
0.006
0.004
0.001
0.013
0.138
IQR, interquartile range; CT, computed tomography; VCT, bladder volume measured from simulation CT scans; VB-SCAN, bladder volume 
scanned by bladder scan prior to simulation CT scans; Vx-x week, bladder volume scanned by bladder scan at post-RT x-x week. 
Fig. 1. A Pearson correlation scatter plot for 20 patients between 
the two different bladder volume detection methods. CT, 
computed tomography.
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the bladder volumes contoured during the simulation CT and 
the baseline bladder volumes measured through the bladder 
ultrasound scan before the simulation CT were compared using 
Pearson correlation test. The bladder volumes measured during 
the RT and the baseline bladder volumes were compared 
using Wilcoxon signed rank test. Absolute and relative bladder 
volume changes (from the baseline) of all patients were also 
calculated each time. Then, using the median values of the 
measurements and interquartile range (IQR), a graph was 
drawn. It was defined statistically significant when p < 0.05 
and SPSS ver. 20.0.0 (IBM, Armonk, NY, USA) was used. 
Results
1. Measurement of bladder volume
Twenty patients were scheduled to receive bladder ultrasound 
scans at a median number of 18 times (range, 15 to 19 times; 
3 days a week according to the RT schedule) in total. Ninety 
percent of the scans were carried out as planned, and patients 
had scans at a median number of 16 times (range, 12 to 19 
times) in total. The median bladder volume measured using 
simulation CT was 427 mL (IQR, 291 mL; range, 74 to 1,172 
mL). The median volume measured using bladder ultrasound 
scan before the simulation CT on the same day was 417 mL 
(IQR, 222 mL; range, 147 to 1,245 mL). There was strong linear 
correlation (R = 0.93, p < 0.001; R2 = 0.86, p < 0.001) between 
the two results (Fig. 1). The bladder volume measurements and 
the number of patients are recorded in Table 2. 
2. Time trends of bladder volume 
The time trends of bladder volume were depicted in Fig. 2. 
Measured volumes during RT were always below the baseline 
volume, and most were of statistical significance (12/16) or 
borderline significance (3/16). On the third day of the third 
week (3-3 weeks) after the RT, the median volume decreased 
by 38.9% to 261 mL (IQR, 157 mL), and at by the third day of 
the sixth week (6-3 weeks), it was reduced by 59.3% to 175 
mL (IQR, 121 mL). The relative and absolute bladder volume 
changes from each patient’s baseline values are displayed in 
Figs. 3 and 4. Compared to the baseline, bladder volume was 
reduced by 38% (standard deviation [SD], 14%) or 161 mL 
(SD, 53 mL) on average every week for 6 weeks. To see the 
intrapatient variation, we calculated overall mean and SD of 
Fig. 3. Absolute bladder volume change from baseline over 
the course of treatment. Error bars represent the median ± 
interquartile range.
Fig. 4. Relative bladder volume change from baseline over the 
course of treatment. Error bars represent the median ± inter-
quartile range.
Fig. 2. Bladder volume measured by bladder scan over the course 
of treatment. Error bars represent the median ± interquartile 
range. 
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each patient’s standard deviation (mean ± SD, 155 ± 100 mL).
Discussion and Conclusion
This study demonstrated that during pelvic RT of rectal cancer 
patients with full bladder, there are wide variations in bladder 
volume as well as significant reduction in bladder volume from 
the baseline. As far as we are aware, this study is the first to 
analyze variations in bladder volume and time trend during RT 
in patients with rectal cancer. 
There have been many studies on the accuracy of bladder 
ultrasound scan [15,17,18]. Ahmad et al. [15] used bladder 
phantom to prove that bladder volume measured with CT or 
bladder ultrasound scan agrees with real bladder volume. It 
also reported that the difference between measurements of 4 
healthy volunteers’ bladder volume before and after urination 
equaled to actual urination volume. Although this study also 
showed strong positive correlation (R = 0.89), there is a slight 
difference from other studies. This may be due to the time 
gap between CT scan and bladder ultrasound scan, which 
range from as little as a few minutes to as much as an hour. In 
order to minimize such error when evaluating the accuracy of 
bladder ultrasound scan, two bladder ultrasound scans (before 
and after CT scan) may be necessary. 
With regards to prostate cancer, there have been many 
studies reported on bladder volume [11,14,18,19]. Nakamura 
et al. [14] reported that measurements of bladder volume 
during RT using megavoltage CT over the course of treatment 
showed 38% of mean volume reduction from the baseline 
at the end of treatment (p < 0.001). Other studies that used 
daily or weekly bladder ultrasound scans reported 16-50% of 
volume reduction from the baseline [6,11,18]. In the case of 
cervix cancer, Ahmad et al. [15] and other studies that used 
bladder ultrasound scan reported an average of 71% of volume 
reduction. In our study, there was 59% reduction, which is 
roughly consistent with the results from prostate cancer 
studies. We also observed the bladder volume was already 
decreased at the first week of treatment (median, 417 mL) 
when compared to those at the time of simulation as baseline 
(211 to 278 mL). The most plausible explanation is that the full 
bladder instruction at the first visit alone was not sufficient to 
maintain the patient’s compliance until and though treatment 
(the interval between first visit and treatment start was 
generally one week).
That bladder volume is not reproducible and rather reduces 
every time means that RT dose on organ at risk could be higher 
than planned. Therefore, efforts to minimize the reduction of 
bladder volume are needed. Stam et al. [17] and O’Doherty 
et al. [18] showed that providing labor-intensive education 
to patients could help maintain bladder volume consistency. 
O’Doherty et al. [18] instructed 41 patients to drink 350 mL of 
water and retain their urine for an hour and a half, and then 
asked them about their bladder fullness. Only 25 of them were 
given patient information sheet, and the bladder volumes of 
the two groups were compared. Patient information sheet 
was developed by a multidisciplinary team, and it contained 
the information regarding the importance of full bladder, 
how to achieve a comfortably full bladder successfully, and 
how to manage if the patient could not hold the full bladder. 
Patients without the information sheet showed a significant 
reduction in bladder volume (mean, 362 mL → 251 mL), but 
the other group maintained consistency (mean, 286 mL → 312 
mL). Stam et al. [17] provided bio-feedback to only 18 of 34 
patients and not for the remaining 16 patients, then compared 
to two groups. To elaborate, if daily measurements of bladder 
volume were below 80% or above 120% of the baseline 
bladder volume, patients were given negative feedback, and 
if the measurements were between 80% and 120%, they 
were given positive feedback (drink the same amount of 
water the next day). The group with bio-feedback showed 7% 
improvement. Our institution is also planning to develop ways 
to educate and perform prospective evaluations on patients in 
order to raise rectal cancer patients’ compliance to full bladder 
instruction during the course of treatment.
There are several limitations to this study; therefore, 
interpreting the results requires some caution. First of all, 
although the study was a retrospective non-interventive 
observation study, there could have been unexpected bio-
feedback in the process of bladder ultrasound scan, which 
could have affected the result. Secondly, this study included 
not only patients who underwent preoperative RT but also 
6 patients who received postoperative RT. Patients who had 
underwent an operation could have had bowel adhesion and 
showed different complications after receiving RT, which 
could have affected the result as well. Even so, this study is 
the first to prove that there are bladder volume variations and 
a reduction in bladder volume in not only prostate and cervix 
cancer but also rectal cancer patients. Moreover, our results 
will serve as the basis for implementation of bladder training 
to patients receiving RT with full bladder. 
Our institution plans to continue studying in order to develop 
the optimal bladder ultrasound scan schedule and patient 
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2009;82:321-7.
11. Nijkamp J, Doodeman B, Marijnen C, Vincent A, van Vliet-
Vroegindeweij C. Bowel exposure in rectal cancer IMRT using 
prone, supine, or a belly board. Radiother Oncol 2012;102:22-
9.
12. Kim TH, Chie EK, Kim DY, et al. Comparison of the belly board 
device method and the distended bladder method for 
reducing irradiated small bowel volumes in preoperative 
radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol 
Phys 2005;62:769-75.
13. Park W, Huh SJ, Lee JE, et al. Variation of small bowel sparing 
with small bowel displacement system according to the 
physiological status of the bladder during radiotherapy for 
cervical cancer. Gynecol Oncol 2005;99:645-51.
14. Nakamura N, Shikama N, Takahashi O, et al. Variability in 
bladder volumes of full bladders in definitive radiotherapy 
for cases of localized prostate cancer. Strahlenther Onkol 
2010;186:637-42. 
15. Ahmad R, Hoogeman MS, Quint S, Mens JW, de Pree I, Heijmen 
BJ. Inter-fraction bladder filling variations and time trends 
for cervical cancer patients assessed with a portable 3- 
dimensional ultrasound bladder scanner. Radiother Oncol 
2008;89:172-9.
16. Yoon HI, Chung Y, Kim JH, et al. The efficacy of the change 
in belly board aperture location by the addition of bladder 
compression device for radiotherapy of rectal cancer. J Korean 
Soc Ther Radiol Oncol 2010;28:231-7. 
17. Stam MR, van Lin EN, van der Vight LP, Kaanders JH, Visser 
AG. Bladder filling variation during radiation treatment of 
prostate cancer: can the use of a bladder ultrasound scanner 
and biofeedback optimize bladder filling? Int J Radiat Oncol 
education method, and ultimately find effective intervention 
methods by identifying patients with wide bladder volume 
variations or those at high risk of bladder volume reduction. 
Moreover, compared to three-dimensional conformal RT, 
further study of bladder filling will be necessary for the pelvic 
intensity modulated RT that requires longer treatment time 
and different dose distribution to the organ at risks.
In conclusion, there were wide variations in bladder volume 
during treatment between rectal cancer patients who received 
concurrent chemotherapy and those who were treated with 
pelvic RT. Moreover, there was significant reduction from the 
baseline volume. This study was able to measure the bladder 
volume in a non-invasive manner using ultrasound-bladder 
scanner. 
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